
Journal of Clinical Oncology - ASCO Publications
Mar 19, 2025 · Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. Through research, education, and promotion of the highest-quality, equitable patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy.
Journal of Clinical Oncology: Vol 43, No 11 - ASCO Publications
Jan 22, 2025 · Accelerating Myeloma Drug Development: Will Minimal Residual Disease Replace Progression-Free Survival as an Intermediate Surrogate End Point? Automatic for the People: What Has Machine Learning Analysis of Positron Emission Tomography Left for the Physician?
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for …
3 days ago · This randomized, open-label study was performed at 51 Japanese institutions and recruited treatment-naïve patients with nonsquamous NSCLC with uncommon EGFR mutations, excluding exon 20 insertions and T790M mutations. Patients were randomly assigned 2:1 to receive afatinib (30 or 40 mg orally, at the treating physician's discretion) or a combination of platinum (cisplatin or carboplatin) and ...
Journal of Clinical Oncology - Wikipedia
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is …
American Society of Clinical Oncology - ASCO
Welcome to the new ASCO.org! ASCO.org has a new look and feel, making it easier than ever to find premier oncology research from ASCO Meetings and JCO Journals, and offering customized recommendations for signed-in users.
Phase I/II Study of Adaptive Manufactured Lentiviral Anti …
Mar 31, 2025 · Seventeen patients with R/R MCL received a single dose of LV20.19 CAR T cells at 2.5 × 10 6 cells/kg (phase I = three patients; phase II = 14 patients). The best overall response rate (ORR) was 100% (complete response [CR] = 88%; partial response = 12%) and the phase II efficacy threshold for day-90 CR rate was exceeded.
Journal of Clinical Oncology - LWW
The Journal of Clinical Oncology (JCO) serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. In print and in electronic format, JCO strives to publish the highest quality articles dedicated to clinical research.
Journal of Clinical Oncology (JCO) Podcast
The Journal of Clinical Oncology podcast, hosted by Dr. Shannon Westin and Dr. Davide Soldato, presents analyses and discussions centered on the latest findings published in ASCO’s esteemed Journal of Clinical Oncology.
Japanese Journal of Clinical Oncology | Oxford Academic
Japanese Journal of Clinical Oncology (JJCO) is an online only multidisciplinary journal for clinical oncologists. JJCO publishes high quality articles on medical oncology, clinical trials, radiology, surgery, basic research, epidemiology, and palliative …
Jayco - High Quality & Design - Award Winning RVs | Jayco
For over 50 years, Jayco has been providing the keys to freedom. We design and build RV's with exploration in mind, so you can make memories on your own terms. No alarms, no rides to catch, no reservations and no worries - just family, fun and relaxation.
- Some results have been removed